Cargando…

Negative attitudes about medications for opioid use disorder among criminal legal staff

BACKGROUND: Stigma is a barrier to the treatment of opioid use disorder (OUD) in the criminal legal system. Staff sometimes have negative attitudes about medications for OUD (i.e., MOUD), but there is little research on what drives these attitudes. How staff think about criminal involvement and addi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moore, Kelly E., Siebert, Shania L., Kromash, Rachelle, Owens, Mandy D., Allen, Diamond C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948914/ https://www.ncbi.nlm.nih.gov/pubmed/36845981 http://dx.doi.org/10.1016/j.dadr.2022.100056

Ejemplares similares

Treatment setting among individuals with opioid use and criminal legal involvement, housing instability, or Medicaid insurance, 2015-2021
por: Shearer, Riley D., et al.
Publicado: (2023)

Insights into the link between drug use and criminality: Lifetime offending of criminally-active opiate users
por: Pierce, Matthias, et al.
Publicado: (2017)

Knowledge and attitudes of medical staff in Chinese psychiatric hospitals regarding COVID-19
por: Shi, Yudong, et al.
Publicado: (2020)

Public attitudes toward legally coerced biological treatments of criminals
por: Berryessa, Colleen M., et al.
Publicado: (2016)

Primary care provider attitudes, experiences and practices about cannabidiol (CBD) and barriers to patient-provider communication about CBD use: A qualitative study
por: Sharma, Pravesh, et al.
Publicado: (2022)

Medicaid expansion and opioid supply policies to address the opioid overdose crisis
por: Shakya, Shishir, et al.
Publicado: (2022)

Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder
por: Scherrer, Jeffrey F., et al.
Publicado: (2022)

A qualitative exploration of the eight dimensions of wellness in opioid use disorder recovery during the postpartum period
por: Mallahan, Stephanie, et al.
Publicado: (2023)

Opportunities to expand postpartum support for those in recovery from opioid use disorder: Results from a qualitative study
por: Allen, Alicia, et al.
Publicado: (2023)

Cannabis vaping among high school seniors in adult-use, medical, and prohibited legal contexts
por: Maynard, Christian P, et al.
Publicado: (2023)

Educating patients about Internet-delivered cognitive behaviour therapy: Perceptions among treatment seekers and non-treatment seekers before and after viewing an educational video
por: Soucy, Joelle N., et al.
Publicado: (2016)

Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes
por: Durgin, Caitlyn J., et al.
Publicado: (2023)

Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City
por: Scheidell, Joy D, et al.
Publicado: (2022)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic pain
por: Anderson Goodell, Erin M., et al.
Publicado: (2021)

The Medico-Legal, Legal, and Moral Aspects of Criminal Abortion and Infanticide
por: Eve, Robert Campbell
Publicado: (1894)

Systematic Review of Criminal and Legal Involvement After Substance Use and Mental Health Treatment Among Veterans: Building Toward Needed Research
por: Timko, Christine, et al.
Publicado: (2020)

Under-representation of key demographic groups in opioid use disorder trials
por: Rudolph, Kara E., et al.
Publicado: (2022)

COVID-19 impact on opioid overdose after jail release in Massachusetts
por: Friedmann, Peter D., et al.
Publicado: (2023)

In utero and post-natal opioid exposure followed by mild traumatic brain injury contributes to cortical neuroinflammation, mitochondrial dysfunction, and behavioral deficits in juvenile rats
por: Gowen, Austin M., et al.
Publicado: (2023)

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder
por: Hefner, Kathryn, et al.
Publicado: (2022)

Differential expression of NPAS4 in the dorsolateral prefrontal cortex following opioid overdose
por: Sosnowski, David W., et al.
Publicado: (2022)

Association of HDAC8 Expression with Pathological Findings in Triple Negative and Non-Triple Negative Breast Cancer: Implications for Diagnosis
por: Menbari, Mohammad-Nazir, et al.
Publicado: (2020)

Contextualizing prescription opioid misuse and heroin use within dimensional models of drug involvement
por: Dash, Genevieve F., et al.
Publicado: (2022)

The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses
por: Bohler, Robert M., et al.
Publicado: (2022)

About the complexity of two-stage stochastic IPs
por: Klein, Kim-Manuel
Publicado: (2021)

The impact of education on attitudes toward medical cannabis
por: Clobes, Thomas A., et al.
Publicado: (2021)

Implementing tobacco-free policy in residential substance use disorders treatment: Practice changes among staff
por: Campbell, Barbara K., et al.
Publicado: (2022)

Signal of increased opioid overdose during COVID-19 from emergency medical services data
por: Slavova, Svetla, et al.
Publicado: (2020)

Opioid treatment program prescribing of methadone with community pharmacy dispensing: Pilot study of feasibility and acceptability
por: Brooner, Robert K., et al.
Publicado: (2022)

The association between medication for opioid use disorder and employment outcomes in the U.S.: The relevance of race and ethnicity
por: Hoang, Bai Linh, et al.
Publicado: (2022)

Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States
por: Pollack, Harold A., et al.
Publicado: (2022)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Demographic factors that impact attitudes toward medical cannabis
por: Clobes, Thomas A., et al.
Publicado: (2022)

Some Legal Points in Reference to Criminal Abortion
Publicado: (1898)

Disparities in opioid treatment access and retention among women based on pregnancy status from 2006 to 2017
por: Khachikian, Tenie, et al.
Publicado: (2022)

Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field
por: O'Brien, Peggy L., et al.
Publicado: (2022)

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment
por: Pan, Yue, et al.
Publicado: (2022)

Sustainment of contingency management within opioid treatment programs: COVID-related barriers and innovative workflow adaptations
por: Becker, Sara J., et al.
Publicado: (2021)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8vihtpj638givj10c3tphoad8q